In an APE mouse model, Chen et al. demonstrated miR-106-5p as a novel regulator of PASMC proliferation and pulmonary vascular remodeling, and it performed its functions via targeting neuron-derived orphan receptor-1 (NOR1). The gene discussed is NR4A3; the disease is apparent mineralocorticoid excess.